Public Company News

Transcenta to Present Two Phase I Clinical Trials of TST001 at Upcoming ASCO GI and IGCC

SUZHOU, China, Jan. 12, 2022 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, announces that the TST001 US P...

2022-01-12 15:15 3840

ABL Bio Enters Global Collaboration and License Agreement with SANOFI to Advance ABL301 for the Treatment of Parkinson's Disease

* ABL and SANOFI to collaborate on the development of ABL301, a potential first-in-class bispecific antibody targeting alpha-synuclein and containing a proprietary brain shuttle, for alpha-synucleinopathies, including Parkinson's disease * ABL301 uses ABL's Grabody-B platform technology to ef...

2022-01-12 07:59 4179

IBM Acquires Envizi to Help Organizations Accelerate Sustainability Initiatives and Achieve Environmental Goals

ARMONK, N.Y., Jan. 11, 2022 /PRNewswire/ -- IBM (NYSE: IBM) today announced it has acquired Envizi, a leading data and analytics software provider for environmental performance management. This acquisition builds on IBM's growing investments in AI-powered software, including IBM Maximo asset mana...

2022-01-11 21:00 5066

SOPHiA GENETICS Reports Strong Traction in the Launch Phase of its DEEP-Lung-IV Multimodal Clinical Study

BOSTON and LAUSANNE, Switzerland, Jan. 11, 2022 /PRNewswire/ -- SOPHiA GENETICS SA (NASDAQ: SOPH), the creator of a global data pooling and knowledge sharing platform that advances data-driven medicine, announced today strong traction in the launch phase of their DEEP-Lung-IV clinical study (NCT0...

2022-01-11 20:27 2383

Semiconductor Manufacturing International Corporation Fourth Quarter 2021 Webcast Conference Call

SHANGHAI, Jan. 11, 2022 /PRNewswire/ -- SMIC's fourth quarter 2021 results will be released on the Hong Kong Stock Exchange website (https://www.hkex.com.hk ) and Shanghai Stock Exchange website ( http://www.sse.com.cn ) after the close of trading ...

2022-01-11 18:39 6756

Aim Strong Growth in Business Results and Actively Deliver Returns to Shareholders

HONG KONG, Jan. 11, 2022 /PRNewswire/ -- CNOOC Limited (the "Company", SEHK: 00883) today announces a summary of its business strategy and development plan for the year 2022. The Company's targeted net production for 2022 is 600 million to 610 million barrels of oil equivalent (BOE), of which,...

2022-01-11 16:50 5111

Fosun Pharma and Insilico Medicine Announce a Strategic, AI-driven Drug Discovery and Development Collaboration to Jointly Advance Multiple Targets

SHANGHAI and NEW YORK, Jan. 11, 2022 /PRNewswire/ -- Shanghai Fosun Pharmaceutical (Group) Co., Ltd ("Fosun Pharma"; Stock Code: 600196.SH, 02196.HK), a leading innovation-driven international healthcare group inChina and Insilico Medicine ("Insilico"), an end-to-end artificial intelligence (AI)...

2022-01-11 16:30 4417

Pixelworks Powers OnePlus 10 Pro Flagship to Deliver Superior Visual Experience

Showcases Always True-To-Life Color Appearance with Great Eye-Comfort Regardless ofAmbient Lighting Conditions SHANGHAI, Jan. 11, 2022 /PRNewswire/ -- Pixelworks, Inc. (NASDAQ: PXLW), a leading provider of innovative video and display processing solutions, and OnePlus, a premium global smartphon...

2022-01-11 16:00 3598

Latest Study Shows Encouraging Results of CanSinoBIO's Inhaled COVID-19 Vaccine as Heterologous Booster

TIANJIN, China, Jan. 11, 2022 /PRNewswire/ -- CanSino Biologics Inc. ("CanSinoBIO") (SSE: 688185, HKEX: 06185) today announced thatPreprints with The Lancet, a collaboration between the research sharing platform SSRN and The Lancet, published a clinical study on the safety and immunogenicity of ...

2022-01-11 15:15 3229

TI advances driver assistance technology to more accurately monitor blind spots and efficiently navigate turns and corners to safely avoid collisions

HANOI, Vietnam, Jan. 11, 2021 /PRNewswire/ -- In an effort to move autonomous driving and vehicle safety forward, Texas Instruments (TI) (Nasdaq: TXN) today announced an expansion of its automotive offerings that can help automakers improve how advanced driver assistance systems (ADAS) sense ob...

2022-01-11 15:00 2698

LTI Partners with Securonix & Snowflake to Strengthen Cybersecurity Offerings

MUMBAI, India, Jan. 11, 2022 /PRNewswire/ -- Larsen & Toubro Infotech  (BSE: 540005) (NSE: LTI ), a global technology consulting and digital solutions company has partnered with Securonix, a leader in next-gen Security Informa...

2022-01-11 13:51 3841

XCMG Launches First Silk Road E-Commerce Station, XCMG-PNG, Offering One-Stop Equipment Purchases in South Pacific Regions

XUZHOU, China, Jan. 11, 2022 /PRNewswire/ -- XCMG Papua New Guinea (XCMG-PNG), the first Silk Road E-Commerce Station by XCMG (SZ:000425), is officially online to provide one-stop service experience for construction machinery customers and users in the South Pacific and surrounding regions withPa...

2022-01-11 10:57 4408

Pfizer Drives Cultural Change in Sustainable and Accessible Data with MicroStrategy

SINGAPORE, Jan. 11, 2022 /PRNewswire/ -- MicroStrategy , the US-based enterprise analytics platform, supportedPfizer, an American multinational pharmaceutical and biotechnology corporation, to usher in a future of sustainable data culture. With the help of solut...

2022-01-11 09:30 3229

Ascletis Announces First Patient Dosed in the Phase II Clinical Trial of ASC42, An In-House Developed, Best-in-Class FXR Agonist for Chronic Hepatitis B Indication

HANGZHOU, China and SHAOXING, China, Jan. 11, 2022 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672) today announces the dosing of the first patient in the Phase II clinical trial of ASC42 for chronic hepatitis B (CHB) indication. The Phase II clinical trial (ClinicalTrials.gov Identifier: NCT051...

2022-01-11 08:30 4181

Xaxis Uses IAS's Context Control Targeting to Raise Awareness for a Fashion Brand

TAIPEI, Jan. 11, 2022 /PRNewswire/ -- Integral Ad Science (Nasdaq: IAS), a global leader in digital media quality, and Xaxis, GroupM's outcome media specialist, used Context Control Targeting to increase campaign performance, website traffic, and brand awareness for a major fashion retailer, all ...

2022-01-11 08:00 3191

Sana Biotechnology, IASO Biotherapeutics, and Innovent Biologics Announce Non-Exclusive License Agreement for Clinically Validated BCMA CAR Construct

SEATTLE, SAN FRANCISCO, SAN JOSE, Calif., NANJING, China, SUZHOU, China and SHANGHAI, Jan. 11, 2022 /PRNewswire/ -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on creating and delivering engineered cells as medicines, IASO Biotherapeutics ("IASO Bio"), a clinical-stage biopharmace...

2022-01-11 05:30 4992

SKF acquires additive manufacturing company

GOTHENBURG, Sweden, Jan. 11, 2022 /PRNewswire/ -- SKF has completed the acquisition of Laser Cladding Venture n.v. (LCV), an additive manufacturing company based inBelgium. LCV is a niche engineering start-up specialized in various additive manufacturing technologies and processes, which can be ...

2022-01-11 00:15 4725

Buybacks of series B shares in AB Electrolux during week 01, 2022

STOCKHOLM, Jan. 10, 2022 /PRNewswire/ -- During the period January 03 - January 07, 2022 AB Electrolux (LEI code 549300Y3HHZB1ZGFPJ93) has repurchased in total 342,312 own series B shares (ISIN: SE0016589188) as part of the buyback program initiated by the Board of Directors in order to optimize ...

2022-01-10 22:56 2741

Everest Medicines Will Participate in a Clinical Trial with Gilead and MSD to Evaluate Trodelvy® in Combination with KEYTRUDA® (pembrolizumab) in First-Line Metastatic Non-Small Cell Lung Cancer

SHANGHAI, Jan. 10, 2022 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), today announced it will participate in a study pursuant to a clinical trial collaboration between Gilead and MSD (Merck & Co., Inc.,  Kenilworth, N...

2022-01-10 21:35 5105

Invitation to Autoliv's Q4, 2021 Earnings Call

STOCKHOLM, Jan. 10, 2022 /PRNewswire/ -- Autoliv Inc., plans to publish its Financial Report for the fourth quarter 2021 onFriday, January 28, 2022 at 12:00 Central European Time (CET). The report will be available at www.autoliv.com In addition, a teleconference will take place the same day. T...

2022-01-10 21:22 2812
1 ... 815816817818819820821 ... 901